Global Pharmaceutical Market Will Shift From The Plate Or - Pharmaceutical Market - Pharmaceutical

2009, the amount of global pharmaceutical sales growth of 7.0%

, reaching 837 billion U.S. dollars. With the "blockbuster" drug patent expires, generic drug market varieties increased, an increased product availability, payment of enhanced side impact, emerging market expansion and reconfiguration of the global pharmaceutical market, the future Drugs Will be the main battlefield in Asia, Africa and Latin America markets shift.

4 20 , IMS announced the global pharmaceutical market in 2009, the latest data. Statistics show that in constant exchange rates, in 2009 the amount of global pharmaceutical sales growth of 7.0%, reaching 837 billion U.S. dollars. The use of generic drugs and the rise of emerging markets significantly impact on the pharmaceutical market in 2009, the emerging pharmaceutical market growth rate of 10% to 16%, and the pharmaceutical market growth in developed countries is only about 5%. Analysis pointed out that with "blockbuster" drug patent expires, generic drug market varieties increased, an increased product availability, payment of enhanced side impact, emerging market expansion and reconfiguration of the global pharmaceutical market, the main battlefield of the future of medicine will be to Asia, Africa and Latin America markets shift.

Global market growth of 5.1% contributed to Lipitor

2009, the global pharmaceutical market continued to grow sales, amounted to 837 billion U.S. dollars, an increase of 5.1%, which is only 1.9% increase in 2008, a marked improvement. But overall, the global pharmaceutical market, pharmaceutical sales growth is still at historically low levels. The listing of generic drugs, people tend to use cheaper generic drugs and innovative drug patents expire, pharmaceutical market growth slowed down Dengjun developed countries affect the global pharmaceutical market expansion to become an important factor.

2009, the top 10 global pharmaceutical market sales amount of over 50 billion dollars. The world's largest multinational pharmaceutical group Pfizer's lipid-lowering drugs produce atorvastatin (Lipitor, Lipitor) still occupy the top spot, but the drug's sales in 2009, year 2008, down 0.3% to 13.288 billion dollars.

2009, the global pharmaceutical market's No. 2 product is the world's third largest pharmaceutical company Sanofi-Aventis of France produced anticoagulant Plavix (clopidogrel, Plavix), the drug the past 5 years sales growth, but growth rates have fallen, in 2009, only 7.9% annual growth compared with 2008, nearly 9 percent drop.

3rd largest global pharmaceutical product sales of AstraZeneca's anti-ulcer drug esomeprazole (Nexium, Nexium), 2009 annual sales up 7.1% to 8.236 billion U.S. dollars. The drug was nearly three years, steady growth. With patents on drugs Lipitor is about to expire, the products sold are largest in the world potential.

Pfizer continued to hold top spot Roche The largest increase

Serious impact on the financial crisis, global economic environment, the global pharmaceutical market, sales of the top 10 companies in sales growth and decline in equal shares, of which growth for Novartis, AstraZeneca, Roche, Eli Lilly and Abbott. Pfizer is still among the top global pharmaceutical market value, but sales dropped for two consecutive years 2008,2009 already. The actual exchange rates, in 2009 Pfizer sales of 57.024 billion U.S. dollars, compared with 2008, a decrease of 1.653 billion U.S. dollars, a decrease of more than 2007, 2.885 billion U.S. dollars. Ranked No. 2 in the Merck company sales by 2008 has maintained steady growth, but in 2009 the global market, sales declined compared to 2008 decreased by 1.3%, to 525 million U.S. dollars.

The global pharmaceutical market in 2009, sales of top 10 enterprises to increase the amount and growth rate of the largest companies are Roche, an increase of 8.18%, sales revenue increased by 2.478 billion U.S. dollars; down the most tragic is that Johnson Companies, down to 9.63%; ranking increase for Novartis, Sanofi-Aventis, Eli Lilly, respectively, from 4, 5 and 10 up to 3, 4 and 9, which Novartis (the world's largest Generic Enterprises) growth may lead to the global financial crisis, declining consumption, countries in order to reduce health care costs, encourage the use of generic drugs, while Sanofi-Aventis (vaccine production giants) may benefit from the growth of the global vaccine market demand, 2009 strong.

by: gaga

POST COMMENT

Exposed Press Release | GLOBAL VIP LAUNCH | Top Network Marketing Campaign How Many Drop Shipping Suppliers Does Worldwide Brands Have? eFoods Global Reviews – A critical review of eFoods Global Water Over 50% Of The Shanghai City Into A Global Green Electricity - Hydropower, Clean Energy - Hp Ranked First In Global Pc Sales Charts Of 2010 The list of the ten best-selling cell phone in global, the 1000 yuan machine of nokia is the first Grab The Important Information About Global Resorts Network Things to Know While Purchasing Paper Shredders Pay attention to the global warming: why this spring "fever"? World Mobile Applications Market Advanced technologies, Global Forecast 2010 to 2015 If The New Global President Of Truman's Visit To China (figure) - Direct Marketing, Direct Benefits of Purchasing Wholesale Piercing Supply World Smart Phones Market Advanced Technologies, Global Forecast and Winning Imperatives 2010 to 2015